Amir Nashat, Director at FATE THERAPEUTICS INC (FATE), sold 34,952 shares at $16.67 ($583K) on 2018-12-13, disclosed to the SEC on 2018-12-17.
Open-market sale of $583k FATE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.67 | 118 | $2K | 0.3% |
| 2 | $16.67 | 172 | $3K | 0.5% |
| 3 | $16.67 | 334 | $6K | 1.0% |
| 4 | $16.67 | 17,164 | $286K | 49.1% |
| 5 | $16.67 | 17,164 | $286K | 49.1% |
| Total | $16.67 avg | 34,952 |
| $583K |
| 100% |
| Filing → |
| SRRK | BUY | 2022-06-24 | $6.2M | — | Filing → |
| MORF | SELL | 2021-05-25 | $20.4M | — | Filing → |
| MTCR | BUY | 2020-09-22 | $3.0M | — | Filing → |